Closure of ostium secundum atrial septum defect with the Atriasept occluder: Early European experience

Objectives: This multicentre study sought to report the safety and efficacy of the ATRIASEPT septal occluder to repair atrial septal defect (ASD). Background: The ATRIASEPT is a low profile, flexible, double disk occluder with centering system specifically designed for closure of ostium secundum ASD...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2010-06, Vol.75 (7), p.1091-1095
Main Authors: Stolt, Valérie Steiger, Chessa, Massimo, Aubry, Pierre, Juliard, Jean-Michel, Schraeder, Rainer, Berger, Alexandre, Goy, Jean-Jacques
Format: Article
Language:English
Subjects:
Adult
atrial septal defect
Cardiac Catheterization - adverse effects
Cardiac Catheterization - instrumentation
congenital heart disease
Echocardiography, Doppler, Color
Echocardiography, Transesophageal
Europe
Female
Heart Septal Defects, Atrial - diagnostic imaging
Heart Septal Defects, Atrial - physiopathology
Heart Septal Defects, Atrial - therapy
Humans
Male
Middle Aged
percutaneous intervention
Prosthesis Design
Recovery of Function
Septal Occluder Device
Time Factors
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: This multicentre study sought to report the safety and efficacy of the ATRIASEPT septal occluder to repair atrial septal defect (ASD). Background: The ATRIASEPT is a low profile, flexible, double disk occluder with centering system specifically designed for closure of ostium secundum ASD. Method: Patients were enrolled from four participating European sites and followed up for 12 months post procedure. Outcomes were evaluated, including closure success and incidence of adverse events. Results: Seventy‐six patients received the ATRIASEPT device. Mean size of the defect was 15 ± 4 mm. Closure success was observed in 69 patients (89%) at the end of the procedure. Sixty‐four patients had a six‐month follow up with a complete closure by 58 patients (90%). Minor adverse events occurred in two patients. Significant functional improvement was reported by all symptomatic patients. Conclusion: Percutaneous closure of ASD ostium secundum type defects with the ATRIASEPT is safe and effective with high success rate and excellent mid‐term outcome. © 2010 Wiley‐Liss, Inc.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.22394